Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap

EDITOR'S BLOG
Friday, February 03, 2017
SANOFI AND BOEHRINGER INGELHEIM CONFIRM CLOSING OF BUSINESS SWAP
Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap

Sanofi and Boehringer Ingelheim have confirmed that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi’s animal health business (Merial) and Boehringer Ingelheim’s consumer healthcare (CHC) business, has been successfully closed in most markets on January 1st 2017. This closing marks the successful outcome of the business swap which started with exclusive negotiations in December 2015. The closing of the acquisition of Merial in Mexico and the Merial and CHC swap in India have been delayed pending receipt of certain regulatory approvals but both are expected to close early 2017.

 

Olivier Brandicourt, M.D., Chief Executive Officer of Sanofi, stated: “With this successful closing of the business swap with Boehringer Ingelheim, Sanofi is building a strong and innovative CHC Global Business Unit. The integration of Boehringer Ingelheim’s highly skilled CHC team and its well established products, allows Sanofi to enhance our positions in core strategic categories in a promising CHC market. Indeed this market serves the growing expectations of consumers to be more in control of their own health and wellness.”

 

The Chairman of the Board of Managing Directors of Boehringer Ingelheim, Hubertus von Baumbach, said: “This important achievement is the result of a mutually beneficial agreement implemented in the spirit of a shared vision. Driven by the desire to serve the needs of our customer, and enabled by value of our innovative product portfolio, the combined strength of the two organizations will improve Boehringer Ingelheim’s competitiveness in the Animal Health business segment that is so strategically important to our company. We are delighted to welcome the employees of Merial to our team.”

 

Over the last months, Sanofi and Boehringer Ingelheim have diligently prepared for the integration of the businesses and employees as of the first day under new ownership. In the interest of all customers and to ensure uninterrupted business continuity, it is both companies’ priority to achieve a smooth integration of the transferred businesses.

 

Alan Main, Executive Vice President Consumer Healthcare and member of Sanofi’s Executive Committee, will ensure Sanofi’s CHC business including the former Boehringer Ingelheim CHC brands will continue on its growth path. The Boehringer Ingelheim Animal Health business unit will be headed by Dr. Joachim Hasenmaier who will remain as Member of the Boehringer Ingelheim Board of Managing Directors.

Wed Apr 11 03:58:46 +0000 2018
@YazbekWehbe ومش كل حدا "تهبلن" عال TV صار إسمو "إعلامي"
Sat Mar 24 03:58:07 +0000 2018
@YazbekWehbe Hahahahaha u are absolutely right 👍
Tue Mar 06 17:00:53 +0000 2018
How Trendy Clothing Can Get YOU In Shape https://t.co/ZjvGbhRjdI Tips/How-Trendy-Clothing-Can-Get-YOU-In-Shape via @FitnStyleme
Wed Jan 24 06:37:06 +0000 2018
Sun Jan 14 10:52:33 +0000 2018
Be your own #hero! #fitnstyleme https://t.co/472TWWttON
Fri Jan 12 07:58:07 +0000 2018
Ultherapy: A Non-Surgical Way to Lift and Tone the Skin https://t.co/lEsyzeBG1V
Thu Jan 04 06:38:45 +0000 2018
RT @rimamaktabi: أدركت اليوم أني توقفت عن وضع أهداف جديدة عند بداية كل عام! أعيش كل يوم بيومه، أقوم بالرياضة وأتناول الطعام الصحي، وأصلي وأ…
Thu Jan 04 06:33:53 +0000 2018
Want to Feel Younger Than You Really Are? https://t.co/rsup0zKpjf
Sun Dec 31 05:51:41 +0000 2017
Love & bonding https://t.co/ySKeF3sAGC
Tue Dec 05 04:25:50 +0000 2017